Cargando…

Predictors for Uptake of Vaccines Offered during the Second Year of Life: Second Dose of Measles-Containing Vaccine and Meningococcal Serogroup A-Containing Vaccine, Ghana, 2020

Background: Understanding the drivers of coverage for vaccines offered in the second year of life (2YL) is a critical focus area for Ghana’s life course approach to vaccination. This study characterizes the predictors of vaccine receipt for 2YL vaccines—meningococcal serogroup A conjugate vaccine (M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muhoza, Pierre, Shah, Monica P., Gao, Hongjiang, Amponsa-Achiano, Kwame, Quaye, Pamela, Opare, William, Okae, Charlotte, Aboyinga, Philip-Neri, Opare, Kwadwo L., Wardle, Melissa T., Wallace, Aaron S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611024/ https://www.ncbi.nlm.nih.gov/pubmed/37896919 http://dx.doi.org/10.3390/vaccines11101515

Ejemplares similares

Community Barriers, Enablers, and Normative Embedding of Second Year of Life Vaccination in Ghana: A Qualitative Study
por: Wolff, Brent, et al.
Publicado: (2023)

Evaluation of Container Clinics as an Urban Immunization Strategy: Findings from the First Year of Implementation in Ghana, 2017–2018
por: Shaum, Anna, et al.
Publicado: (2023)

Introduction of the Second Dose of Measles Containing Vaccine in the Childhood Vaccination Programs Within the WHO Africa Region – Lessons Learnt
por: Masresha, Balcha G, et al.
Publicado: (2018)

An 11-year trend of rubella incidence cases reported in the measles case-based surveillance system, Ghana
por: Dongdem, Anthony Zunuo, et al.
Publicado: (2021)

Meningococcal serogroup B vaccines: Estimating breadth of coverage
por: Donald, Robert G. K., et al.
Publicado: (2016)

Anti-Factor H Antibody Reactivity in Young Adults Vaccinated with a Meningococcal Serogroup B Vaccine Containing Factor H Binding Protein
por: Sharkey, Kelsey, et al.
Publicado: (2019)

Estimation of the Impact of Meningococcal Serogroup C Universal Vaccination in Italy and Suggestions for the Multicomponent Serogroup B Vaccine Introduction
por: Martinelli, Domenico, et al.
Publicado: (2015)

Are physicians obligated to tell parents about the meningococcal serogroup B vaccine?
por: Robinson, Dr Joan L
Publicado: (2015)

Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
por: Gamougam, Kadidja, et al.
Publicado: (2015)

Parental awareness and utilization of meningococcal serogroup B vaccines in the United States
por: Srivastava, Amit, et al.
Publicado: (2020)

The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae
por: Semchenko, Evgeny A, et al.
Publicado: (2019)

Immunization delivery in the second year of life in Ghana: the need for a multi-faceted approach
por: Nyaku, Mawuli, et al.
Publicado: (2017)

Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future
por: Holst, Johan, et al.
Publicado: (2013)

Diversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine
por: Tzanakaki, Georgina, et al.
Publicado: (2014)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
por: Rivero-Calle, Irene, et al.
Publicado: (2019)

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil
por: Tauil, Márcia de Cantuária, et al.
Publicado: (2014)

Meningococcal serogroup B vaccine in Italy: state-of-art, organizational aspects and perspectives
por: SIGNORELLI, C., et al.
Publicado: (2015)

2. Understanding Patient Preferences for Meningococcal Serogroup B Vaccines in the United States
por: Johnson, Reed, et al.
Publicado: (2020)

A comparison of national vaccination policies to prevent serogroup B meningococcal disease
por: Sulis, Giorgia, et al.
Publicado: (2022)

Timeliness Vaccination of Measles Containing Vaccine and Barriers to Vaccination among Migrant Children in East China
por: Hu, Yu, et al.
Publicado: (2013)

Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study
por: Daugla, DM, et al.
Publicado: (2013)

Invasive Meningococcal Disease and Meningococcal Serogroup B Vaccination in Adults and Their Offspring: Knowledge, Attitudes, and Practices in Italy (2019)
por: Riccò, Matteo, et al.
Publicado: (2023)

Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study
por: Ohm, Milou, et al.
Publicado: (2021)

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
por: Hedari, Carine P, et al.
Publicado: (2014)

Genetic associations with a fever after measles-containing vaccines
por: Klein, Nicola P., et al.
Publicado: (2020)

Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine
por: Marjuki, Henju, et al.
Publicado: (2019)

Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011–2017
por: Fernandez, Katya, et al.
Publicado: (2019)

Rotavirus vaccine product switch in Ghana: An assessment of service delivery costs, switching costs, and cost-effectiveness
por: Owusu, Richmond, et al.
Publicado: (2023)

Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015
por: Folaranmi, Temitope, et al.
Publicado: (2015)

Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine
por: van Ravenhorst, Mariëtte B., et al.
Publicado: (2018)

Evaluation of the Impact of Immunization Second Year of Life Training Interventions on Health Care Workers in Ghana
por: Tchoualeu, Dieula Delissaint, et al.
Publicado: (2021)

Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China
por: Meng, Fan-Ya, et al.
Publicado: (2017)

Carriage Rate and Effects of Vaccination after Outbreaks of Serogroup C Meningococcal Disease, Brazil, 2010
por: Sáfadi, Marco Aurelio Palazzi, et al.
Publicado: (2014)

Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016
por: Soeters, Heidi M., et al.
Publicado: (2017)

Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018
por: Bwaka, Ado, et al.
Publicado: (2019)

Exploring spatial variations and the individual and contextual factors of uptake of measles-containing second dose vaccine among children aged 24 to 35 months in Ethiopia
por: Teshale, Achamyeleh Birhanu, et al.
Publicado: (2023)

Difficulties in Eliminating Measles and Controlling Rubella and Mumps: A Cross-Sectional Study of a First Measles and Rubella Vaccination and a Second Measles, Mumps, and Rubella Vaccination
por: Wang, Zhifang, et al.
Publicado: (2014)

Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines
por: Serra, Lidia, et al.
Publicado: (2021)

Meningococcal Vaccinations
por: Crum-Cianflone, Nancy, et al.
Publicado: (2016)

Meningococcal disease serogroup C
por: Dickinson, Félix O, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j35gr018vhljl2b7h5n62envbj